DVL1 and neoplasm: In breast tumors, mir-1247-5p promotes tumor growth via the Dishevelled1(DVL1)/Wnt/β-catenin signaling pathway (31), which promotes the differentiation of skeletal cells and accelerates bone regeneration (32).